Kazia Therapeutics Limited
(NASDAQ: KZIA)
|
5:13 PM UTC, 10/29/24 | |||
---|---|---|---|---|
Last: $5.27 | Change: +0.61 | %Change: +13.09% | Volume: 126,344 |
Open: | $ 4.71 | Volume: | 126,344 | |
---|---|---|---|---|
High: | $ 5.50 | Yield(%) | 0.00 | |
Low: | $ 4.70 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 4.09 | Market Cap ($): | 11.01M | |
EPS ($) | n/a | Shares Out: | 2.36M |
% Price Change (last 4 weeks): | 8.40 |
---|---|
% Price Change (last 13 weeks): | 16.50 |
% Price Change (last 26 weeks): | 31.27 |
% Price Change (last 52 weeks): | -12.08 |
% Price Change (year to date): | 6.03 |
Return on Equity (%): | -132.12 |
---|---|
Return on Assets (%): | -64.43 |
Return on Invested Capital (%): | -84.17 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
50-day Moving Average: | $4.02 |
---|---|
200-day Moving Average: | $3.43 |
Avg. Daily Vol. (last 50 days): | 148,413 |
Avg. Daily Vol. (last 200 days): | 471,025 |
52-wk high: | $15.80 |
52-wk low: | $1.87 |
Bid: | $5.23 |
Ask: | $5.48 |
Kazia Therapeutics Ltd. is a clinical stage oncology company, which engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
|
Kazia Therapeutics Limited
Three International Towers 300 Barangaroo Avenue Level 24 Sydney NS 2000 Phone: 61.2.9472.4101 Fax: n/a http://www.kaziatherapeutics.com |
Earnings (1year) ($): | -4.44 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 3.52 |
Cash Flow ($): | -5.49 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 3.30 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.42 |
---|---|
Current Ratio (x): | 1.42 |
LT Debt/Equity (x): | 0.00 |
Total Debt/Equity (x): | 14.91 |